← Every company
Amylyx Pharmaceuticals Inc SEC Filings
What Amylyx Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AMLX overview →Filings on file
59
since Dec 16, 2021
Warning signs
0
none filed
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Sep 8, 2026 | Material agreement 8-K | Read ↗ |
| Aug 20, 2026 | Material agreement 8-K | Read ↗ |
| Aug 6, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2026 | Results announced 8-K | Read ↗ |
| Jun 4, 2026 | Shareholder vote 8-K | Read ↗ |
| May 7, 2026 | Quarterly report 10-Q | Read ↗ |
| May 7, 2026 | Results announced 8-K | Read ↗ |
| Mar 3, 2026 | Annual report 10-K | Read ↗ |
| Mar 3, 2026 | Results announced 8-K | Read ↗ |
| Nov 6, 2025 | Quarterly report 10-Q | Read ↗ |
| Nov 6, 2025 | Results announced 8-K | Read ↗ |
| Sep 10, 2025 | Material agreement 8-K | Read ↗ |
| Aug 7, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 7, 2025 | Results announced 8-K | Read ↗ |
| Jun 5, 2025 | Shareholder vote 8-K | Read ↗ |
| May 8, 2025 | Quarterly report 10-Q | Read ↗ |
| May 8, 2025 | Results announced 8-K | Read ↗ |
| Mar 4, 2025 | Annual report 10-K | Read ↗ |
| Mar 4, 2025 | Results announced 8-K | Read ↗ |
| Jan 10, 2025 | Material agreement 8-K | Read ↗ |
| Nov 7, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 7, 2024 | Results announced 8-K | Read ↗ |
| Aug 8, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 8, 2024 | Results announced 8-K | Read ↗ |
| Jul 10, 2024 | Acquisition or sale completed 8-K | Read ↗ |
| Jun 21, 2024 | Material agreement 8-K | Read ↗ |
| Jun 6, 2024 | Shareholder vote 8-K | Read ↗ |
| May 9, 2024 | Quarterly report 10-Q | Read ↗ |
| May 9, 2024 | Results announced 8-K | Read ↗ |
| Apr 4, 2024 | Restructuring 8-K | Read ↗ |
| Mar 14, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 22, 2024 | Annual report 10-K | Read ↗ |
| Feb 22, 2024 | Results announced 8-K | Read ↗ |
| Nov 9, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 9, 2023 | Results announced 8-K | Read ↗ |
| Aug 10, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 10, 2023 | Results announced 8-K | Read ↗ |
| Jun 9, 2023 | Shareholder vote 8-K | Read ↗ |
| May 11, 2023 | Quarterly report 10-Q | Read ↗ |
| May 11, 2023 | Results announced 8-K | Read ↗ |
| Mar 21, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 13, 2023 | Annual report 10-K | Read ↗ |
| Mar 13, 2023 | Results announced 8-K | Read ↗ |
| Dec 6, 2022 | Material agreement 8-K | Read ↗ |
| Nov 10, 2022 | Quarterly report 10-Q | Read ↗ |
| Nov 10, 2022 | Results announced 8-K | Read ↗ |
| Nov 2, 2022 | Executive or director change 8-K | Read ↗ |
| Oct 7, 2022 | Share offering 424B4 | Read ↗ |
| Oct 4, 2022 | Share offering S-1 | Read ↗ |
| Aug 11, 2022 | Results announced 8-K | Read ↗ |
| Aug 11, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 11, 2022 | Results announced 8-K | Read ↗ |
| Jun 9, 2022 | Shareholder vote 8-K | Read ↗ |
| May 12, 2022 | Quarterly report 10-Q | Read ↗ |
| May 12, 2022 | Results announced 8-K | Read ↗ |
| Mar 31, 2022 | Annual report 10-K | Read ↗ |
| Mar 31, 2022 | Results announced 8-K | Read ↗ |
| Jan 10, 2022 | Share offering 424B4 | Read ↗ |
| Dec 16, 2021 | Share offering S-1 | Read ↗ |
Source: Amylyx Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AMLX
Company overviewEverything on AMLX in one place, with the price.Insider tradingWhat AMLX's own officers and directors buy and sell.Planned salesSales AMLX insiders have filed notice of.Who owns itEvery manager reporting a position in AMLX.Funds holding itWhich funds and ETFs hold AMLX, and how big a bet.LobbyingWhat AMLX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AMLX's account, and who they worked for.PatentsWhat AMLX is filing at the patent office.